| 1 |
FP293 |
ICG- Enhanced Focal therapy for Persistent Reactivation in Retinoblastoma |
Dr. PREMA K.V. SUBRAMANIAM |
Dr. PREMA K.V. SUBRAMANIAM |
| 2 |
FP363 |
Impact of mass genetic testing on a single day for RB1 mutation in patients of Retinoblastoma |
DR. PUJA MAITRA |
DR. PUJA MAITRA |
| 3 |
FP663 |
Systemic neoadjuvant chemotherapy in extensive periocular sebaceous gland carcinoma:Longterm results |
DR. ANSHIKA LUTHRA |
DR. ANSHIKA LUTHRA |
| 4 |
FP911 |
Risk factors for local tumour recurrence and metastasis in sebaceous gland carcinoma of the eyelid |
Dr.Deepthi Elizabeth Kurian |
Dr. SHAIFALI CHAHAR |
| 5 |
FP949 |
How deep is deep? – An analysis of multi-level biopsy in orbital lesions |
Dr. SHAIFALI CHAHAR |
Dr. SHAIFALI CHAHAR |
| 6 |
FP1033 |
Secondary super-selective intra-arterial chemotherapy in advanced and refractory retinoblastoma |
DR. ROLIKA BANSAL |
DR. ROLIKA BANSAL |
| 7 |
FP1905 |
Intravitreal topotecan for vitreous seeds in retinoblastoma: A long-term review of 91 eyes |
DR MRITTIKA SEN |
DR MRITTIKA SEN |
| 8 |
FP1932 |
High risk histopathological features in primary versus secondary enucleation for retinoblastoma |
Prof.BHAVNA CHAWLA |
DR. MANUMURALEEKRISHNA |
| 9 |
FP2118 |
“Time to Diagnosis” in newly diagnosed retinoblastoma: interim analysis from InPOG-RB-19-01. |
Dr. SIMA DAS |
Dr. SIMA DAS |